Recent Advancement in Exosome-Inspired Lipid Nanovesicles for Cell-Specific Drug Delivery

被引:1
作者
Sunkara, Siva Prasad [1 ]
Kar, Nihar Ranjan [2 ]
Kareemulla, Shaik [3 ]
Sarma, Koushik Narayan [4 ]
Thool, Komal Umare [5 ]
Katual, Manoj Kumar [6 ]
Kondrapu, Pydiraju [7 ]
机构
[1] Chebrolu Hanumaiah Inst Pharmaceut Sci, Dept Pharm, Guntur, Andhra Prades, India
[2] Centur Univ Technol & Management, Dept Pharm, Balasore, Odisha, India
[3] Maharishi Markandeshwar Deemed Univ, MM Coll Pharm, Dept Pharm Practice, Ambala, Haryana, India
[4] Assam Town Univ, Dept Pharm, Gauhati, Assam, India
[5] Shree Ramdevbaba Coll Engn & Management Nagpur, Dept Elect & Commun Engn, Nagpur, Maharashtra, India
[6] Guru Kashi Univ, Univ Coll Pharm, Dept Pharmaceut, Sardulgarh Rd, Bhatinda, Punjab, India
[7] Aditya Pharm Coll, Dept Pharm, ADB Rd, Kakinada 533437, Andhra Prades, India
关键词
Exosome; Exo-LNVs; Surface modification; Drug delivery system; Extracellular vesicles; Therapeutic cargo; EXTRACELLULAR VESICLES; NANO-CARRIERS; TRANSPORT; RELEASE;
D O I
10.5530/ijpi.14.4.119
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Exosomes are small nanovesicles that are produced through the fusion of multiple veins and plasma membranes, then escaping into adjacent body fluids. Considerable attention has been paid to them due to their potential as delivery vehicles for drugs. Exosomes play a key role in many physiological processes that occur both in healthy and ill states. The production of exosomes depends on the state of the disease, but the disease itself often serves the opposite function by promoting more cell damage and stress. Traditional drug delivery methods often face limitations in terms of specificity, targeted delivery and drug release kinetics. Exosomes have emerged as promising candidates for drug delivery due to their natural ability to selectively deliver cargoes to recipient cells. Exosomes are taken up through various mechanisms, including endocytosis and fusion with target cells. They can encapsulate poorly soluble drugs, enhancing their bioavailability and improving their therapeutic efficacy. Exosomes inspired Lipid Nanovesicles (Exo-LNVs) have shown promising results as drug delivery vehicles. Exosomes have considerable potential as sophisticated vehicle for the delivery of targeted drugs and genes due to their unique characteristics, including inherent stability, minimal immunity and exceptional ability to penetrate tissues and cells. Therapeutic interventions have the capacity to increase effectiveness, reduce side effects and increase patient compliance. Exosomes have the ability to transport various therapeutic by encapsulating different substrates such as nucleic acids, proteins and small molecules. Recent advancements in exosome-inspired lipid nanovesicles have opened up new possibilities for cell-specific drug delivery. These nanovesicles mimic the composition and structure of exosomes, which are naturally occurring extracellular vesicles released by cells. By incorporating therapeutic agents into the lipid nanovesicles, they can effectively target and deliver drugs to specific cells of interest. This review article aims to summarize the current literature on Exo-LNVs and discuss their potential as drug delivery vehicles. A systematic search was conducted to identify relevant studies and relevant data were extracted and analyzed. The review covers various aspects of Exo-LNVs, including their composition, preparation methods and applications in various disease conditions.
引用
收藏
页码:1085 / 1095
页数:11
相关论文
共 50 条
  • [21] Lemon-derived exosome-like nanovesicles: A promising avenue for drug delivery system and therapeutic applications in biomedical science
    Khadilkar, Mansi
    Arora, Sanchit
    Sahu, Rohan Chand
    Rawat, Satyavati
    Kumar, Dinesh
    Agrawal, Ashish Kumar
    FOOD BIOSCIENCE, 2025, 68
  • [22] Surface modification of lipid-based nanocarriers for cancer cell-specific drug targeting
    Kim C.H.
    Lee S.G.
    Kang M.J.
    Lee S.
    Choi Y.W.
    Journal of Pharmaceutical Investigation, 2017, 47 (3) : 203 - 227
  • [23] CELL-SPECIFIC SIRNA DELIVERY BY PEPTIDES AND ANTIBODIES
    Lee, Sang-Kyung
    Siefert, Alyssa
    Beloor, Jagadish
    Fahmy, Tarek M.
    Kumar, Priti
    METHODS IN ENZYMOLOGY, VOL 502: PROTEIN ENGINEERING FOR THERAPEUTICS, PT A, 2012, 502 : 91 - 122
  • [24] Cell-Specific Intracellular Anticancer Drug Delivery from Mesoporous Silica Nanoparticles with pH Sensitivity
    Luo, Zhong
    Cai, Kaiyong
    Hu, Yan
    Zhang, Beilu
    Xu, Dawei
    ADVANCED HEALTHCARE MATERIALS, 2012, 1 (03) : 321 - 325
  • [25] Cancer Cell-Specific Fluorescent Prodrug Delivery Platforms
    Ma, Siyue
    Kim, Ji Hyeon
    Chen, Wei
    Li, Lu
    Lee, Jieun
    Xue, Junlian
    Liu, Yuxia
    Chen, Guang
    Tang, Bo
    Tao, Wei
    Kim, Jong Seung
    ADVANCED SCIENCE, 2023, 10 (16)
  • [26] Targeting Tetraspanins at Cell Interfaces: Functional Modulation and Exosome-Based Drug Delivery for Precise Disease Treatment
    Xu, Kun
    Feng, Huixia
    Zhao, Rui
    Huang, Yanyan
    CHEMMEDCHEM, 2025, 20 (02)
  • [27] Drug Targeting and Nanotherapeutic Advancement in the Treatment of Rheumatoid Arthritis: Recent Progress in Drug Delivery Systems
    Deshmukh, Rohitas
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024,
  • [28] Celery (Apium graveolens L.) Exosome-like Nanovesicles as a New-Generation Chemotherapy Drug Delivery Platform against Tumor Proliferation
    Lu, Xin
    Han, Qing
    Chen, Jiachen
    Wu, Tingyu
    Cheng, Yirui
    Li, Fan
    Xia, Weiliang
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (22) : 8413 - 8424
  • [29] Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: a Cost-Effective Alternative
    Goh, Wei Jiang
    Zou, Shui
    Ong, Wei Yi
    Torta, Federico
    Alexandra, Alvarez Fernandez
    Schiffelers, Raymond M.
    Storm, Gert
    Wang, Jiong-Wei
    Czarny, Bertrand
    Pastorin, Giorgia
    SCIENTIFIC REPORTS, 2017, 7
  • [30] Microfluidic synthesis of lipid-based nanoparticles for drug delivery: recent advances and opportunities
    Mehraji, Sima
    DeVoe, Don L.
    LAB ON A CHIP, 2024, 24 (05) : 1154 - 1174